VR-Based Cognitive Stimulation Games for Delirium Prevention
Virtual Reality-Based Cognitive Stimulation Games for Enhancing Attention and Preventing Delirium in Older Surgical Patients With Cognitive Impairment
The Methodist Hospital Research Institute
90 participants
Apr 24, 2026
INTERVENTIONAL
Conditions
Summary
This trial aims to evaluate the feasibility, safety, and acceptability of a virtual reality (VR)-based cognitive stimulation game to reduce postoperative delirium among older surgical patients at high risk due to pre-existing cognitive impairment.
Eligibility
Inclusion Criteria3
- Men and women ≥65 years of age
- Have a pre-existing diagnosis of cognitive impairment (Montreal Cognitive Assessment Score of 15-24)
- Elective or emergency major surgery with the expectation of admission to the Intensive Care Unit following the surgery for three days following surgery
Exclusion Criteria10
- Pre-existing Intubation and invasive ventilation;
- history of severe mental illness;
- admission for a drug overdose;
- severe vertigo;
- history of severe postoperative nausea and vomiting;
- hearing and visual impairment;
- preexisting severe dementia (Montreal Cognitive Assessment Score < 15; and
- active delirium at the time of screening for eligibility criteria.
- Active suicidal ideation or behavior Screen failure after surgery
- Prolonged intubation after surgery (more than 24 hours)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The ReCognition virtual reality (VR) software is delivered via an Oculus Quest 2 device. This three-dimensional simulated software was designed to improve attention and executive functions. The VR session will occur once per day for 20 minutes.
This virtual reality software is delivered via an Oculus Quest 2 device. The Oculus Quest 2 device will be used to watch an educational movie. The VR session will occur once per day for 20 minutes.
Reality orientation therapy focused on time, place, and person, administered twice daily, typically at the beginning and end of nursing shifts.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07641153